GANX
Price
$1.87
Change
+$0.06 (+3.31%)
Updated
Oct 17 closing price
Capitalization
67.22M
20 days until earnings call
Intraday Buy/Sell Signals
IRD
Price
$1.87
Change
-$0.14 (-6.97%)
Updated
Oct 17 closing price
Capitalization
112.03M
Intraday Buy/Sell Signals
Interact to see
Advertisement

GANX vs IRD

Header iconGANX vs IRD Comparison
Open Charts GANX vs IRDBanner chart's image
Gain Therapeutics
Price$1.87
Change+$0.06 (+3.31%)
Volume$671.18K
Capitalization67.22M
Opus Genetics
Price$1.87
Change-$0.14 (-6.97%)
Volume$367.92K
Capitalization112.03M
GANX vs IRD Comparison Chart in %
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GANX vs. IRD commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a Hold and IRD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (GANX: $1.87 vs. IRD: $1.87)
Brand notoriety: GANX and IRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 92% vs. IRD: 99%
Market capitalization -- GANX: $67.22M vs. IRD: $112.03M
GANX [@Biotechnology] is valued at $67.22M. IRD’s [@Biotechnology] market capitalization is $112.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileIRD’s FA Score has 0 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • IRD’s FA Score: 0 green, 5 red.
According to our system of comparison, IRD is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 5 TA indicator(s) are bullish while IRD’s TA Score has 2 bullish TA indicator(s).

  • GANX’s TA Score: 5 bullish, 5 bearish.
  • IRD’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, GANX is a better buy in the short-term than IRD.

Price Growth

GANX (@Biotechnology) experienced а -5.08% price change this week, while IRD (@Biotechnology) price change was -4.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

GANX is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRD($112M) has a higher market cap than GANX($67.2M). IRD YTD gains are higher at: 57.143 vs. GANX (-13.426). GANX has higher annual earnings (EBITDA): -17.16M vs. IRD (-61.46M). IRD has more cash in the bank: 32.4M vs. GANX (6.69M). GANX has less debt than IRD: GANX (681K) vs IRD (1M). IRD has higher revenues than GANX: IRD (15.4M) vs GANX (0).
GANXIRDGANX / IRD
Capitalization67.2M112M60%
EBITDA-17.16M-61.46M28%
Gain YTD-13.42657.143-23%
P/E RatioN/AN/A-
Revenue015.4M-
Total Cash6.69M32.4M21%
Total Debt681K1M68%
FUNDAMENTALS RATINGS
IRD: Fundamental Ratings
IRD
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GANXIRD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RHEPA0.380.06
+20.22%
Regional Health Properties, Inc.
LKNCY40.100.60
+1.52%
Luckin Coffee Inc.
EQGPF64.98N/A
N/A
EQB Inc
FRFC49.80N/A
N/A
First Robinson Financial Corporation
NASB35.10N/A
N/A
NASB Financial, Inc.

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+3.31%
COYA - GANX
41%
Loosely correlated
+0.95%
TERN - GANX
36%
Loosely correlated
-2.32%
EYPT - GANX
36%
Loosely correlated
+0.69%
AXON - GANX
36%
Loosely correlated
+2.84%
WVE - GANX
36%
Loosely correlated
-0.76%
More

IRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with ARRY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
-6.97%
ARRY - IRD
35%
Loosely correlated
-0.17%
RLYB - IRD
33%
Loosely correlated
-3.39%
GANX - IRD
33%
Poorly correlated
+3.31%
TERN - IRD
33%
Poorly correlated
-2.32%
MURA - IRD
32%
Poorly correlated
N/A
More